AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,160.00p
   
  • Change Today:
    -58.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.67m
  • Volume: 243,892
  • Market Cap: £157,548m
  • RiskGrade: 123

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
31-Dec-20 Interim 59.00¢ 14-Sep-09 05-Aug-09 07-Aug-09
31-Dec-20 1st Interim 90.00¢ 14-Sep-20 13-Aug-20 14-Aug-20
  2nd Interim 190.00¢ 29-Mar-21 25-Feb-21 26-Feb-21
  Final 171.00¢ 15-Mar-10 03-Feb-10 05-Feb-10
31-Dec-21 1st Interim 90.00¢ 13-Sep-21 12-Aug-21 13-Aug-21
  2nd Interim 197.00¢ 28-Mar-22 24-Feb-22 25-Feb-22
31-Dec-22 1st Interim 93.00¢ 12-Sep-22 11-Aug-22 12-Aug-22
  2nd Interim 197.00¢ 27-Mar-23 23-Feb-23 24-Feb-23
31-Dec-23 1st Interim 93.00¢ 11-Sep-23 10-Aug-23 11-Aug-23
  2nd Interim 197.00¢ 25-Mar-24 22-Feb-24 23-Feb-24
31-Dec-24 1st Interim 100.00¢ 09-Sep-24 08-Aug-24 09-Aug-24
  2nd Interim 210.00¢ 24-Mar-25 20-Feb-25 21-Feb-25

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,160.00p
Change Today -58.00p
% Change -0.57 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 243,892
Shares Issued 1,550.67m
Market Cap £157,548m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.86% below the market average93.86% below the market average93.86% below the market average93.86% below the market average93.86% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
30.62% below the market average30.62% below the market average30.62% below the market average30.62% below the market average30.62% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Income
61.43% below the market average61.43% below the market average61.43% below the market average61.43% below the market average61.43% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
87.23% above the market average87.23% above the market average87.23% above the market average87.23% above the market average87.23% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 08-Jul-2025

Time Volume / Share Price
12:21 54 @ 10,160.00p
12:21 45 @ 10,160.00p
12:21 100 @ 10,160.00p
12:21 17 @ 10,162.00p
12:21 185 @ 10,162.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page